03-13-2021, 12:25 PM
Telegram Post -
AstraZeneca WHOSE VACCINE IS NOW SUSPENDED IN 10 EU COUNTIES ENTERED INTO A DEAL WITH A BRAZILIAN MANUFACTURER JULY 2020 ON CONDITION THEY HAD THE RIGHT TO DECLARE THE PANDEMIC OVER BY JULY 2021.
From the Financial Times October 7 2020
“AstraZeneca, which has promised not to profit from its Covid-19 vaccine “during the pandemic”, has the right to declare an end to the pandemic as soon as July 2021, according to an agreement with a manufacturer.
The UK pharmaceutical company, which is developing a vaccine candidate with Oxford university, has said it would provide doses on a cost basis for at least as long as the pandemic lasts.
However, a memorandum of understanding between AstraZeneca and a Brazilian manufacturer, which has been seen by the Financial Times, defines the “Pandemic Period” as ending on July 1 2021. The period could be extended but only if “AstraZeneca acting in good faith considers that the SARS-COV-2 pandemic is not over”, it says.
But cases globally show no sign of tapering. Even optimistic forecasts predict an approved vaccine is unlikely to be widely available for public vaccination campaigns before the middle of next year.
The MoU outlines the conditions of a deal signed in July between AstraZeneca and Fiocruz, a Brazilian public health institution, to produce at least 100m vaccine doses, worth more than $300m.
“It seems that it is the drug companies that determine, in secret deals, who will get access to the vaccine and when”
Pascal Soriot, AstraZeneca’s chief executive, has previously said that a number of factors would influence the company’s assessment of when the pandemic is over, including the World Health Organization’s own analysis, but has not been more specific. He has also declined to disclose a post-pandemic price point.
The future cost of any approved vaccine is a contentious issue after pharmaceutical groups including AstraZeneca, received hundreds of millions of dollars in public money to fast track development.
Some companies have said from the outset that they can only develop the vaccine for profit.
Others, such as AstraZeneca and Johnson & Johnson, have agreed to provide doses on a cost basis for at least as long as the pandemic lasts.
Several drugmakers have already signed sales agreements with governments but the terms of the contracts are confidential and few details have been released.
AstraZeneca declined to answer specific questions regarding its definition of the “Pandemic Period” or the Fiocruz agreement.
The remaining 2/3 of the article is here https://www.ft.com/content/c474f9e1-8807...4af145b686
AstraZeneca WHOSE VACCINE IS NOW SUSPENDED IN 10 EU COUNTIES ENTERED INTO A DEAL WITH A BRAZILIAN MANUFACTURER JULY 2020 ON CONDITION THEY HAD THE RIGHT TO DECLARE THE PANDEMIC OVER BY JULY 2021.
From the Financial Times October 7 2020
“AstraZeneca, which has promised not to profit from its Covid-19 vaccine “during the pandemic”, has the right to declare an end to the pandemic as soon as July 2021, according to an agreement with a manufacturer.
The UK pharmaceutical company, which is developing a vaccine candidate with Oxford university, has said it would provide doses on a cost basis for at least as long as the pandemic lasts.
However, a memorandum of understanding between AstraZeneca and a Brazilian manufacturer, which has been seen by the Financial Times, defines the “Pandemic Period” as ending on July 1 2021. The period could be extended but only if “AstraZeneca acting in good faith considers that the SARS-COV-2 pandemic is not over”, it says.
But cases globally show no sign of tapering. Even optimistic forecasts predict an approved vaccine is unlikely to be widely available for public vaccination campaigns before the middle of next year.
The MoU outlines the conditions of a deal signed in July between AstraZeneca and Fiocruz, a Brazilian public health institution, to produce at least 100m vaccine doses, worth more than $300m.
“It seems that it is the drug companies that determine, in secret deals, who will get access to the vaccine and when”
Pascal Soriot, AstraZeneca’s chief executive, has previously said that a number of factors would influence the company’s assessment of when the pandemic is over, including the World Health Organization’s own analysis, but has not been more specific. He has also declined to disclose a post-pandemic price point.
The future cost of any approved vaccine is a contentious issue after pharmaceutical groups including AstraZeneca, received hundreds of millions of dollars in public money to fast track development.
Some companies have said from the outset that they can only develop the vaccine for profit.
Others, such as AstraZeneca and Johnson & Johnson, have agreed to provide doses on a cost basis for at least as long as the pandemic lasts.
Several drugmakers have already signed sales agreements with governments but the terms of the contracts are confidential and few details have been released.
AstraZeneca declined to answer specific questions regarding its definition of the “Pandemic Period” or the Fiocruz agreement.
The remaining 2/3 of the article is here https://www.ft.com/content/c474f9e1-8807...4af145b686